Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

754 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J. Topol EJ, et al. Among authors: van de werf f. Am Heart J. 2000 Jun;139(6):927-33. doi: 10.1067/mhj.2000.105107. Am Heart J. 2000. PMID: 10827369 Clinical Trial.
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease.
Harrington RA, Armstrong PW, Graffagnino C, Van De Werf F, Kereiakes DJ, Sigmon KN, Card T, Joseph DM, Samuels R, Granett J, Chan R, Califf RM, Topol EJ. Harrington RA, et al. Among authors: van de werf f. Circulation. 2000 Aug 15;102(7):728-35. doi: 10.1161/01.cir.102.7.728. Circulation. 2000. PMID: 10942739 Clinical Trial.
Redefining medical treatment in the management of unstable angina.
Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster V, Gibler WB, Harrington RA, King SB 3rd, Kleiman NS, Theroux P, Topol EJ, Van de Werf F, White HD, Willerson JT. Braunwald E, et al. Among authors: van de werf f. Am J Med. 2000 Jan;108(1):41-53. doi: 10.1016/s0002-9343(99)00416-7. Am J Med. 2000. PMID: 11059440 Review.
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Newby LK, Ohman EM, Christenson RH, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Van De Werf F, Pfisterer M, Hasselblad V, Califf RM, Topol EJ. Newby LK, et al. Among authors: van de werf f. Circulation. 2001 Jun 19;103(24):2891-6. doi: 10.1161/01.cir.103.24.2891. Circulation. 2001. PMID: 11413076 Clinical Trial.
Progress culminating from ten years of clinical trials on thrombolysis for acute myocardial infarction. GUSTO-I Steering Committee. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Van de Werf F, Califf RM, Armstrong PW, Bates ER, Ross AM, Kleinman NS, Topol EJ. Van de Werf F, et al. Eur Heart J. 1995 Aug;16(8):1024-6. doi: 10.1093/oxfordjournals.eurheartj.a061042. Eur Heart J. 1995. PMID: 8665962 No abstract available.
Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
Topol EJ, Califf RM, Van de Werf F, Simoons M, Hampton J, Lee KL, White H, Simes J, Armstrong PW. Topol EJ, et al. Among authors: van de werf f. Circulation. 1997 Feb 18;95(4):1072-82. doi: 10.1161/01.cir.95.4.1072. Circulation. 1997. PMID: 9054772 Review. No abstract available.
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.
Pfisterer M, Cox JL, Granger CB, Brener SJ, Naylor CD, Califf RM, van de Werf F, Stebbins AL, Lee KL, Topol EJ, Armstrong PW. Pfisterer M, et al. Among authors: van de werf f. J Am Coll Cardiol. 1998 Sep;32(3):634-40. doi: 10.1016/s0735-1097(98)00279-4. J Am Coll Cardiol. 1998. PMID: 9741504 Free article. Clinical Trial.
754 results